Systematic review / meta-analysis / 2017
B-vitamin supplements modestly reduced stroke risk but did not affect myocardial infarction or death.
An updated systematic review analyzed 15 randomized controlled trials with 71,422 participants evaluating vitamin B6, B9, or B12 supplements over 1 to 7.3 years. Compared to placebo, homocysteine-lowering interventions reduced stroke (4.3% vs. 5.1%; RR 0.90, 95% CI 0.82-0.99; 10 trials, n=44,224). However, no differences occurred for myocardial infarction (RR 1.02, 95% CI 0.95-1.10), all-cause mortality (RR 1.01, 95% CI 0.96-1.06), or serious adverse events (RR 1.07, 95% CI 1.00-1.14).
- Study type
- Systematic review and meta-analysis of randomized controlled trials
- Who was studied
- 71,422 participants in 15 randomized controlled trials
- What was measured
- Stroke, myocardial infarction, all-cause mortality, and adverse events
THE PAPER
Homocysteine-lowering interventions for preventing cardiovascular events.
Martí-Carvajal AJ, Solà I, Lathyris D, Dayer M. Cochrane Database Syst Rev, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.